Cantor Fitzgerald Initiates Coverage On NextGen Healthcare with Overweight Rating, Announces Price Target of $21
Portfolio Pulse from richadhand@benzinga.com
Cantor Fitzgerald analyst Steven Halper has initiated coverage on NextGen Healthcare (NASDAQ:NXGN) with an Overweight rating and a price target of $21.
August 28, 2023 | 11:41 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
NextGen Healthcare has been given an Overweight rating and a price target of $21 by Cantor Fitzgerald.
The Overweight rating from Cantor Fitzgerald indicates that the analyst believes NXGN will outperform the market in the near future. This positive outlook, coupled with a price target of $21, suggests potential upside for the stock, which could drive its price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100